Induction of BCL2-Interacting Killer, BIK, is Mediated for Anti-Cancer Activity of Curcumin in Human Head and Neck Squamous Cell Carcinoma Cells

被引:21
作者
Xi, Yue [1 ,2 ]
Gao, Hang [1 ]
Callaghan, Michael U. [2 ]
Fribley, Andrew M. [2 ,3 ]
Garshott, Danielle M. [2 ]
Xu, Zhi-Xiang [1 ,4 ]
Zeng, Qinghua [1 ,4 ]
Li, Yu-Lin [1 ]
机构
[1] Jilin Univ, Norman Bethune Coll Med, Minist Educ, Key Lab Pathobiol, Changchun 130021, Peoples R China
[2] Wayne State Univ, Dept Otolaryngol, Carmen & Ann Adams Dept Pediat, Detroit, MI 48201 USA
[3] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA
[4] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA
基金
中国国家自然科学基金;
关键词
Curcumin; Bik; caspase-9; caspase-3; apoptosis; squamous cell carcinoma; natural product; head and neck cancer; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; NF-KAPPA-B; CANCER STATISTICS; SIGNAL TRANSDUCER; APOPTOSIS; ACTIVATION; PATHWAYS; DEATH; PROLIFERATION;
D O I
10.7150/jca.11185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Naturally occurring diarylheptanoid curcumin (CUR), a principal component of the Asian spice turmeric, has been shown to have anti-cancer effects in many tumor types. However, a detailed mechanism regarding CUR induced tumor cell killing remain to be comprehensively explored. Using two head neck squamous cell carcinoma (HNSCC) cell lines FaDu (hypopharyngeal) and Cal27 (tongue), we demonstrated a novel mechanism by which CUR levies the cytotoxic effect. We found that CUR induced upregulation of pro-apoptotic Bik, down-regulation of survival signaling by AKT and NF-kappa B prior to the induction of the caspase-cascade reduction of cell proliferation, are primary mechanisms of CUR-induced cell death, thus providing insights into the anti-tumor activity of CUR in HNSCC cells.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 50 条
[1]   Intracellular signal transduction pathway proteins as targets for cancer therapy [J].
Adjei, AA ;
Hidalgo, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5386-5403
[2]   Treating cancer by blocking cell signals [J].
Adjei, AA ;
Hidalgo, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5279-5280
[3]   Targeting multiple signal transduction pathways in lung cancer [J].
Adjei, Alex A. .
CLINICAL LUNG CANCER, 2005, 7 :S39-S44
[4]   Molecular targets of dietary agents for prevention and therapy of cancer [J].
Aggarwal, BB ;
Shishodia, S .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) :1397-1421
[5]   Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy [J].
Amit, Ido ;
Wides, Ron ;
Yarden, Yosef .
MOLECULAR SYSTEMS BIOLOGY, 2007, 3 (1)
[6]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[7]   Molecular therapy in head and neck oncology [J].
Bernier, Jacques ;
Bentzen, Soren M. ;
Vermorken, Jan B. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) :266-277
[8]   Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-XL enhances antitumor effects in squamous cell carcinoma of the head and neck [J].
Boehm, Amanda L. ;
Sen, Malabika ;
Seethala, Raja ;
Gooding, William E. ;
Freilino, Maria ;
Wong, Silvia Man Yan ;
Wang, Shaomeng ;
Johnson, Daniel E. ;
Grandis, Jennifer Rubin .
MOLECULAR PHARMACOLOGY, 2008, 73 (06) :1632-1642
[9]   Caspases induce cytochrome c release from mitochondria by activating cytosolic factors [J].
Bossy-Wetzel, E ;
Green, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :17484-17490
[10]  
BOYD JM, 1995, ONCOGENE, V11, P1921